Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma
Clinical trial NCT04443829 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04443829
- Sponsor
- University College, London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-23
- Primary completion
- 2024-12-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.